Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA-G expression: immune privilege for tumour cells?

F A Cabestre1, S Lefebvre, P Moreau

  • 1Service de Recherches en Hémato-immunologie, CEA/DRM/DSV, Hôpital Saint-Louis, Centre Hayem, 1 avenue Claude Vellefaux, Paris, Cedex 10, 75475, France.

Seminars in Cancer Biology
|March 27, 1999
PubMed
Summary

Human leukocyte antigen G (HLA-G) expressed by melanoma cells inhibits immune responses. This finding suggests HLA-G is a novel mechanism for tumor cells to evade immune surveillance and elimination.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roles of full-length and Δα1 HLA-G isoforms in NK-cell regulation and vascular SARS-CoV-2 infection.

Human immunology·2026
Same author

Cytometry-based analysis of HLA-G functions according to ILT2 expression.

Human immunology·2020
Same author

Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

HLA-G 2012 conference: the 15-year milestone update.

Tissue antigens·2013
Same author

Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction.

Leukemia·2012

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The non-classical class I antigen HLA-G is crucial for feto-maternal tolerance.
  • HLA-G interacts with inhibitory receptors to suppress natural killer (NK) and T cell functions.

Purpose of the Study:

  • To investigate HLA-G expression in melanoma.
  • To determine the role of HLA-G in tumor immune tolerance and evasion.

Main Methods:

  • Analysis of HLA-G transcription and protein expression in human melanoma cell lines and ex vivo biopsies.
  • Assessment of the impact of HLA-G expression on NK cell cytotoxicity.

Main Results:

  • Melanoma cell lines and biopsies show high levels of HLA-G transcription.

Related Experiment Videos

  • Differential HLA-G isoform transcription and protein expression patterns were observed.
  • Melanoma cells expressing HLA-G were found to inhibit NK cell-mediated lysis.

    • Conclusions:

    • HLA-G expression in melanoma represents a novel mechanism for tumor immune evasion.
    • Tumor-expressed HLA-G may impede the elimination of malignant cells by anti-tumor immune effector cells.
    • This study highlights HLA-G as a potential target for cancer immunotherapy.